Document Migration

PRODUCTS

  • At ProPharma, we offer a unique approach to the traditional Clinical Research Organization (CRO) Full-Service Provider (FSP) model.

  • Chemocatalyzed steps in synthetic routes are known to afford high selectivities, yields and atom economy. A chemocatalytic reaction optimization requires large number of experiments to identify a suitable catalyst, catalyst loading, solvent, temperature, pressure etc. The chemocatalysis team at Aragen Life Sciences has the capabilities to optimize processes using high throughput screening combined with DoE from gram to multikilo scale with ready access to catalysts and ligands.

  • The Challenge: Building Scalable Viral Vector Programs

    Cell and gene therapies offer unprecedented hope for previously untreatable diseases. At the heart of many of these advanced therapies, including both gene therapies and gene-modified cell therapies, are viral vectors, particularly Adeno-Associated Vectors (AAV) and Lentiviral Vectors (LVV), which serve as crucial gene-delivery vehicles.

  • An optimized and effective Contamination Control Strategy (CCS) helps you organization spend less time cleaning and more time manufacturing. Ecolab Life Sciences experts are dedicated to helping you drive the best possible strategy to meet and exceed the GMO Annex 1 CCS requirements.

  • The industry’s leading scalable electroporation technology for high-yield, transient expression of complex proteins, vaccines, and biologics.

    • Rapidly transfect from 75 thousand to 20 billion cells
    • High efficiency and cell viability enable flexible media strategies that can deliver significant cost savings
    • Improved yields from transient expression for decreased development timelines
    • Proprietary Flow Electroporation® Technology
    • Faster production of stable clones
    • ISO-certified and CE-marked

WHITE PAPERS AND CASE STUDIES

NEWS